UY34841A - VIRUS INFECCIOSO DE SCHMALLENBERG DE cADN CLONADOS Y SUS USOS - Google Patents
VIRUS INFECCIOSO DE SCHMALLENBERG DE cADN CLONADOS Y SUS USOSInfo
- Publication number
- UY34841A UY34841A UY0001034841A UY34841A UY34841A UY 34841 A UY34841 A UY 34841A UY 0001034841 A UY0001034841 A UY 0001034841A UY 34841 A UY34841 A UY 34841A UY 34841 A UY34841 A UY 34841A
- Authority
- UY
- Uruguay
- Prior art keywords
- schmallenberg
- infectious virus
- sbv
- clonates
- cdna
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/12011—Bunyaviridae
- C12N2760/12022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/12011—Bunyaviridae
- C12N2760/12041—Use of virus, viral particle or viral elements as a vector
- C12N2760/12043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/12011—Bunyaviridae
- C12N2760/12051—Methods of production or purification of viral material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
La presente invención pertenece al campo de la salud animal y se refiere a una secuencia de ácido n ucleico que comprende el genoma completo de un virus infeccioso de Schmallenberg (SBV) de utilidad para estudiar viremia y enfermedades causadas por SBV en rumiantes y en el desarrollo de vacunas, agentes terapéuticos y diagnósticos para la preven ción, tratamiento y diagnosis de viremia y enfermedades causadas por SBV.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12170630 | 2012-06-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY34841A true UY34841A (es) | 2013-12-31 |
Family
ID=48537980
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY0001034841A UY34841A (es) | 2012-06-01 | 2013-05-31 | VIRUS INFECCIOSO DE SCHMALLENBERG DE cADN CLONADOS Y SUS USOS |
Country Status (5)
Country | Link |
---|---|
US (1) | US9241960B2 (es) |
EP (1) | EP2855512B1 (es) |
AR (1) | AR091239A1 (es) |
UY (1) | UY34841A (es) |
WO (1) | WO2013178711A1 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112014029515A2 (pt) | 2012-06-01 | 2017-07-25 | Boehringer Ingelheim Vetmedica Gmbh | vacina de vírus schmallenberg (sbv), métodos de produção e usos da mesma, virus schmallenberg, usos de seus antígenos e composição de matéria |
EP2855512B1 (en) | 2012-06-01 | 2018-02-28 | Boehringer Ingelheim Vetmedica GmbH | Genomic sequences of schmallenberg virus and uses thereof |
ES2893282T3 (es) * | 2019-05-10 | 2022-02-08 | Pasteur Institut | Un nuevo orthobunyavirus en la encefalitis humana y su diagnóstico y aplicaciones terapéuticas |
CN115057925B (zh) * | 2022-06-22 | 2024-03-26 | 中国检验检疫科学研究院 | 一种抗赤羽病病毒单克隆抗体及其应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080226682A1 (en) | 2007-03-13 | 2008-09-18 | Peros Systems Technologies, Inc. | Immunoactive Compositions for Improved Oral Delivery of Vaccines and Therapeutic Agents |
BR112014029515A2 (pt) | 2012-06-01 | 2017-07-25 | Boehringer Ingelheim Vetmedica Gmbh | vacina de vírus schmallenberg (sbv), métodos de produção e usos da mesma, virus schmallenberg, usos de seus antígenos e composição de matéria |
EP2855512B1 (en) | 2012-06-01 | 2018-02-28 | Boehringer Ingelheim Vetmedica GmbH | Genomic sequences of schmallenberg virus and uses thereof |
-
2013
- 2013-05-29 EP EP13725971.9A patent/EP2855512B1/en active Active
- 2013-05-29 US US13/904,506 patent/US9241960B2/en active Active
- 2013-05-29 WO PCT/EP2013/061126 patent/WO2013178711A1/en active Application Filing
- 2013-05-31 UY UY0001034841A patent/UY34841A/es unknown
- 2013-05-31 AR ARP130101935 patent/AR091239A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
EP2855512B1 (en) | 2018-02-28 |
US20130323210A1 (en) | 2013-12-05 |
WO2013178711A1 (en) | 2013-12-05 |
AR091239A1 (es) | 2015-01-21 |
EP2855512A1 (en) | 2015-04-08 |
US9241960B2 (en) | 2016-01-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR091316A1 (es) | Moleculas de union humanas que se pueden unir y neutralizar a los virus de la influenza b y sus usos | |
UY34918A (es) | Nuevos ácidos 5-aminotetrahidroquinolin-2-carboxílicos y su uso | |
UY33370A (es) | Composiciones farmacéuticas comprendiendo un fármaco inhibidor de la DPP4 y de la pioglitazona, procedimientos de preparación y utilización | |
AR076570A1 (es) | Moleculas de union humanas capaces de neutralizar el virus de la influenza h3n2 y usos de las mismas | |
EA201600476A1 (ru) | Вариант вируса ppcc, клон кднк вируса ppcc европейского типа и их применение | |
DOP2014000170A (es) | Compuestos de imidazopirrolidinona | |
UY33797A (es) | Composiciones farmacéuticas para el tratamiento del vhc | |
BR112012032008A2 (pt) | anticorpos s100a4 e usos terapêuticos do mesmo | |
MX350282B (es) | Molecula de union que tiene actividad neutralizadora del virus de la influenza a, producida a partir de celulas b humanas. | |
GT201500005A (es) | Composiciones de vacuna para la prevencion contra la infeccion por el virus del dengue | |
BR112013020743A2 (pt) | composições e métodos para a terapia e diagnóstico de influenza | |
UY34420A (es) | ?métodos de tratamiento del virus de la hepatitis c con que de gs-7977 y ribavirina, composiciones y usos" | |
BR112014000637A2 (pt) | diagnóstico do mal de alzheimer | |
UY34841A (es) | VIRUS INFECCIOSO DE SCHMALLENBERG DE cADN CLONADOS Y SUS USOS | |
CO7131387A2 (es) | Composiciones y métodos de polipéptidos-complejo de quelato de oligonucleótido | |
CL2018000433A1 (es) | Procedimientos para mejorar la salud de peces de cultivo. | |
CL2015003563A1 (es) | Marcador para trastornos de la esfingomielinasa ácida y sus usos. | |
BR112015002549A2 (pt) | regime de vacinação para proteger uma criança contra infecção ou doença causada por vírus sincicial respiratório, composição imunogênica ou pluralidade de composições imunogênicas, uso de uma composição imunogênica ou de uma pluralidade de composições imunogênicas | |
EA201401352A1 (ru) | Вакцина против вируса шмалленберга (sbv), способы ее получения и применения | |
CO7071133A2 (es) | Diaminopirimidinas utiles como inhibidores del virus sincicial respiratorio (rsv) humano | |
ZA201308672B (en) | Diagnosis of respiratory tract infectious disease using blood specimens | |
BR112014028632A8 (pt) | Composto, composição farmacêutica, e, método para preparar um composto | |
BR112015002984A2 (pt) | composição, vacina para proteger um animal contra uma infecção com bactérias leptospira, e, uso de ácido cítrico. | |
CU20150019A7 (es) | Rotavirus humanos modificados | |
BR112015003074A2 (pt) | composição, vacina para proteger um animal contra uma infecção com bactérias leptospira, e, uso de ácido etilenodiaminatetra-acético. |